Clinical Trial Update: Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hydroxychloroquine plus azithromycin for prevention and treatment of acute respiratory syndrome caused by COVID-19. Status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Acute Respiratory Distress Syndrome, Covid19 | Phase 2 | Status: UNKNOWN